Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
5.77B
Market cap5.77B
Price-Earnings ratio
-69.64
Price-Earnings ratio-69.64
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$94.69
High today$94.69
Low today
$90.40
Low today$90.40
Open price
$94.53
Open price$94.53
Volume
1.30M
Volume1.30M
52 Week high
$105.47
52 Week high$105.47
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

The current Twist Bioscience(TWST) stock price is $92.00, with a market capitalization of 5.77B. The stock trades at a price-to-earnings (P/E) ratio of -69.64.

On 2026-07-14, Twist Bioscience(TWST) stock moved within a range of $90.40 to $94.69. With shares now at $92.00, the stock is trading +1.8% above its intraday low and -2.8% below the session's peak.

Trading activity shows a volume of 1.3M, compared to an average daily volume of 1.56M.

The stock's 52-week range extends from a low of $23.30 to a high of $105.47.

The stock's 52-week range extends from a low of $23.30 to a high of $105.47.

TWST News

Investing.com 1d
Twist Bioscience CFO Adam Laponis sells $226,307 in stock - Investing.com

...

Twist Bioscience CFO Adam Laponis sells $226,307 in stock - Investing.com
Simply Wall St 3d
Is Twist Bioscience’s AI Order Momentum Reshaping Its Core Life Sciences Investment Story?

In recent days, Twist Bioscience attracted concentrated analyst attention as Evercore ISI, Guggenheim, and Barclays all updated their views following discussion...

Is Twist Bioscience’s AI Order Momentum Reshaping Its Core Life Sciences Investment Story?

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.